CSIMarket
 

La Jolla Pharmaceutical Company  (NASDAQ: LJPC)

La Jolla Pharmaceutical's

Competitiveness




 

LJPC Sales vs. its Competitors Q2 2022







Revenue Growth Comparisons




Net Income Comparison


La Jolla Pharmaceutical Company Net Income in the 2 quarter 2022 fell year on year by -34.15%, while most of its competitors have experienced a net loss.

<<  LJPC Stock Performance Comparisons



*Market share is calculated based on total revenue.





Publicly Traded Peers of La Jolla Pharmaceutical Company




Capricor Therapeutics inc
Share Performance



-66.59%
This Quarter



Capricor Therapeutics inc
Profile

Capricor Therapeutics Inc's business model revolves around developing innovative regenerative medicine therapies for the treatment of diseases that have unmet medical needs.

More about Capricor Therapeutics inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 574.917 mill. $ - mill. $ -114.594 mill.

Sources: La Jolla Pharmaceutical Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on La Jolla Pharmaceutical Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.